CAR-T
ProductHeard in 8 episodes across 7 shows since Apr 2026
CAR-T is a personalized cancer immunotherapy in which a patient’s T cells are genetically engineered to recognize and attack cancer cells.
Episodes
This week
Expert statements
Share of the conversation
Mentions of CAR-T per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 31 | 0.02‰ | 2 |
| Sep 2 | 0.03‰ | 1 |
| Oct 19 | 0.01‰ | 1 |
| Nov 13 | 0.01‰ | 1 |
| Nov 15 | 0.02‰ | 1 |
| Nov 20 | 0.02‰ | 1 |
Email alert
Email me when CAR-T comes up on a podcast
One email a week at most, with the new episodes that mention CAR-T. Free, no account needed, unsubscribe in one click.
What experts have said about CAR-T
12 statements · 11 positive · 1 negative
In vivo CAR-T showed approximately 100% response rates durable through five months.
“everybody is essentially at 100% response rate and fairly durable up to five months.”
Open the episode · Episode 202 - November 6, 2026Listen at 59:21
In vivo CAR-T appears promising based on early data.
“it looks like in vivo car t is is fairly promising”
Open the episode · Episode 202 - November 6, 2026Listen at 59:42
CAR-T therapy is highly effective for blood cancers such as multiple myeloma.
“for blood cancers like multiple myeloma, the efficacy is incredible with CAR T therapies now.”
Open the episode · Nvidia's Historic Quarter, SaaS Comeback, Bessent vs Druck, America's Debt Crisis, Cancer VaccineListen at 1:35:08
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
8 episodes featuring CAR-T, newest first
- Nov 20, 2026
Biotech weighs AI disruption against a stronger 2027 deal cycleBiotech HangoutNov 20, 2026 - Nov 15, 2026
Biotech investors weigh gene editing, MASH data and RAS riskBreaking BiotechNov 15, 2026 - Nov 13, 2026
Heart drug failures test genetics-led discoveryThe Readout LoudNov 13, 2026 - Oct 19, 2026
Cancer prevention meets the unfinished science of agingThe Peter Attia DriveOct 19, 2026 - Sep 2, 2026
Moderna turns tumor mutations into personalized cancer vaccinesThe a16z ShowSep 2, 2026 - Aug 31, 2026
Friedberg links America’s economic strain to a socialist turnThe Diary Of A CEO with Steven BartlettAug 31, 2026